14-77218499-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020431.4(TMEM63C):c.-13-302A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.697 in 152,180 control chromosomes in the GnomAD database, including 37,122 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.70 ( 37122 hom., cov: 33)
Consequence
TMEM63C
NM_020431.4 intron
NM_020431.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.959
Publications
4 publications found
Genes affected
TMEM63C (HGNC:23787): (transmembrane protein 63C) Enables calcium activated cation channel activity. Involved in cation transport. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Biomarker of focal segmental glomerulosclerosis. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63C Gene-Disease associations (from GenCC):
- spastic paraplegia 87, autosomal recessiveInheritance: AR Classification: MODERATE, LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM63C | NM_020431.4 | c.-13-302A>T | intron_variant | Intron 2 of 23 | ENST00000298351.5 | NP_065164.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.697 AC: 106043AN: 152062Hom.: 37104 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
106043
AN:
152062
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.697 AC: 106114AN: 152180Hom.: 37122 Cov.: 33 AF XY: 0.700 AC XY: 52049AN XY: 74402 show subpopulations
GnomAD4 genome
AF:
AC:
106114
AN:
152180
Hom.:
Cov.:
33
AF XY:
AC XY:
52049
AN XY:
74402
show subpopulations
African (AFR)
AF:
AC:
27103
AN:
41506
American (AMR)
AF:
AC:
11337
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
2473
AN:
3472
East Asian (EAS)
AF:
AC:
3327
AN:
5168
South Asian (SAS)
AF:
AC:
3484
AN:
4832
European-Finnish (FIN)
AF:
AC:
7890
AN:
10590
Middle Eastern (MID)
AF:
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48064
AN:
67996
Other (OTH)
AF:
AC:
1526
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1674
3348
5023
6697
8371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2360
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.